“Liquid Biopsy for EGFR Mutations in Non-Small Cell Lung Cancer: A Meta-Analysis on Its Potential and Challenges”

https://pubmed.ncbi.nlm.nih.gov/38116291

Meta-analysis shows that liquid biopsy has potential in identifying EGFR mutations in non-small cell lung cancer, but its application in routine diagnostics is still challenging due to non-homogeneous literature data, lack of optimal detection methods, and high costs.